BackTNF Pharmaceuticals Overview

TNF Pharmaceuticals Accounts Payable

Track TNF Pharmaceuticals's accounts payable ($960K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$960308.00
↓ 55.64% YoYΔ $-1.20M vs prior year quarter

Peer trimmed avg / median

Loading

TNF Pharmaceuticals Accounts Payable History

Loading

TNF Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

TNF Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

TNF Pharmaceuticals (TNFA) FAQ

TNF Pharmaceuticals posts a accounts payable of $960K as of March 2026. That compares with $2.2M in the prior-year period — down 55.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, TNF Pharmaceuticals's accounts payable was $2.2M. The latest reading is $960K — a 55.6% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Accounts Payable is one piece of TNF Pharmaceuticals's financial statement story. At $960K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for TNFA's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; TNF Pharmaceuticals's other metric pages and overview cover the third.